Health Lean Analytics, a platform specialized in optimizing hospital operations through data and artificial intelligence, has closed a new funding round, bringing its total capital raised to over €2.1 million. The investment aims to accelerate the company’s entry into the U.S. market.
The company plans to use the funds for international expansion, with the United States as its first target, as well as to support its commercial deployment over the next 12 months and to strengthen its R&D capabilities.
This milestone has been made possible through the addition of Novanta as a strategic partner. Novanta will have representation on the board of directors and will contribute advanced technology to the company. According to the firm, Novanta’s experience will help “tackle this new growth phase and validate the technology in a highly demanding environment.”
The round also includes participation from several family offices, including Inderhabs, Namarel, and Braincats, through an oversubscribed €1.4 million seed round, complemented by a participative loan granted by the Empresa Nacional de Innovación (ENISA).
With this capital injection, Health Lean Analytics aims to consolidate its position in the Spanish market, accelerate the development of new technological solutions, and validate its proposition in various international markets.
“The inclusion of Novanta as an advanced technology partner validates our technological and strategic strength and provides us with the resources and experience needed to accelerate our R&D innovation,” said the company’s co-founder and co-CEO, Mauro Batesteza
cloud technology axon
Xcalibur Smart Mapping, recognised as the global leader in airborne...
